Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Sales and Marketing > New Product Development and Launch > Ensuring Market Focus > Competitive Analysis

Competitive Analysis Research

Pitfalls to Avoid for a Strong Oncology Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Oncology Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new oncology product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5159)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1862.00   Free Excerpt Available


Patient Factors that Shape a Successful Oncology Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Oncology Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new oncology product's market entry... (ID 5157)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Metabolic Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Metabolic Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new metabolic product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5141)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Patient Factors that Shape a Successful Metabolic Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Metabolic Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new metabolic product's market entry... (ID 5139)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1862.00   Free Excerpt Available


Payer Factors that Shape a Successful Metabolic Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Metabolic Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a metabolic product fares in the marketplace... (ID 5138)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1517.00   Free Excerpt Available


Product Factors that Shape a Successful Metabolic Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Metabolic Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New metabolic products are constantly entering the biopharmaceutical marketplace; some therapies are immediate successes while others flounder for months... (ID 5136)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2867.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Cardiovascular Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Cardiovascular Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new cardiovascular product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5132)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Patient Factors that Shape a Successful Cardiovascular Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Cardiovascular Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new cardiovascular product's market entry... (ID 5130)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1824.00   Free Excerpt Available


Payer Factors that Shape a Successful Cardiovascular Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Cardiovascular Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a cardiovascular product fares in the marketplace... (ID 5129)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1785.00   Free Excerpt Available


Product Factors that Shape a Successful Cardiovascular Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Cardiovascular Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New cardiovascular products are constantly entering the biopharmaceutical marketplace; some therapies are immediate successes while others flounder for months... (ID 5127)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2500.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5121)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1947.00   Free Excerpt Available


Resource Allocation and Launch Readiness Factors that Shape a Strong Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions 
Non-members: Click here to review a complimentary excerpt from "Resource Allocation and Launch Readiness Factors that Shape a Strong Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions" STUDY OVERVIEW One of the more difficult aspects of planning a new product launch is balancing the different resource and investment allocations that are needed to prepare the marketplace for a new product... (ID 5120)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1888.00   Free Excerpt Available


Patient Factors that Shape a Successful Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new product's market entry... (ID 5119)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1947.00   Free Excerpt Available


Payer Factors that Shape a Successful Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a product fares in the marketplace... (ID 5118)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1782.00   Free Excerpt Available


Product Factors that Shape a Successful Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New products are constantly entering the biopharmaceutical marketplace; some products are immediate successes while others flounder for months... (ID 5116)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2500.00   Free Excerpt Available


Competitive Intelligence Resources: Budget, Staff Compensation & Leadership 
Non-members: Click here to sign-up for a complimentary tour of "Competitive Intelligence Resources: Budget, Staff Compensation & Leadership" STUDY OVERVIEW Successful competitive intelligence groups (see definition at end of abstract) have sufficient executive support to provide them with key resources they need to operate effectively and accomplish the CI work that is required for meeting the needs of the business... (ID 4981)
Companies Profiled: Abbott, Amadeus IT Group, ALSTOM, IMS, more ...
Price: $2195.00


Effective Competitive Intelligence Stakeholder Relationships & Communications 
Non-members: Click here to sign-up for a complimentary tour of "Effective Competitive Intelligence Stakeholder Relationships & Communications" STUDY OVERVIEW Successful CI leaders and staff know that intelligence organizations (see definition at end of abstract) must be well connected with their key stakeholders to sustain the function’s effectiveness... (ID 4980)
Companies Profiled: Abbott, Amadeus IT Group, ALSTOM, IMS, more ...
Price: $2602.00


Competitive Intelligence (CI): Effective Structure, Alignment and Information Sources 
Non-members: Click here to sign-up for a complimentary tour of "Competitive Intelligence (CI): Effective Structure, Alignment and Information Sources" STUDY OVERVIEW To be effective, a competitive intelligence group (see definition at end of abstract) needs an environment that includes proximity to key customers and/or executives, opportunities for frequent interaction with stakeholders, direct management by an executive champion, alignment with future-focused business leaders, functional independence and, in many cases, a seat at the decision table... (ID 4979)
Companies Profiled: Abbott, Amadeus IT Group, ALSTOM, IMS, more ...
Price: $2521.00


Competitive Intelligence: Organizational Value and High Impact Activities 
Non-members: Click here to sign-up for a complimentary tour of "Competitive Intelligence: Organizational Value and High Impact Activities" STUDY OVERVIEW In today’s volatile business environment, unforeseen market shifts can blindside an unwary company and nullify product forecasts, sales strategies and development plans... (ID 4978)
Companies Profiled: Abbott, Amadeus IT Group, ALSTOM, IMS, more ...
Price: $2277.00


Competitive Intelligence Research Bundle 
Non-Members: To download a complimentary excerpt of this research bundle, please click here... (ID 4802)
Companies Profiled: Abbott Laboratories, 3M Company, Amgen, AstraZeneca, more ...
Price: $2113.00


Identifying and Evaluating Potential Products in Driving Growth through New Product Planning and Strategic Alliances 
Study Overview Knowing how to most effectively identify and evaluate potential products and how to establish decision goals for products to ensure efficiency and accountability is a necessity for any pharmaceutical company... (ID 4681)
Companies Profiled: Eli Lilly, Pfizer, Amgen, Janssen
Price: $1348.95



 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.